SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000042
Filing Date
2020-03-30
Accepted
2020-03-30 08:08:28
Documents
32
Period of Report
2020-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxearningsreleaseq42019.htm 8-K 33595
2 EXHIBIT 99.1 ex991-earningsreleaseq42019.htm EX-99.1 123138
3 EXHIBIT 99.2 phasebiocorporateoverc5e.htm EX-99.2 50403
4 phasebiocorporateoverc5e001.jpg GRAPHIC 59438
5 phasebiocorporateoverc5e002.jpg GRAPHIC 171767
6 phasebiocorporateoverc5e003.jpg GRAPHIC 135869
7 phasebiocorporateoverc5e004.jpg GRAPHIC 96954
8 phasebiocorporateoverc5e005.jpg GRAPHIC 56311
9 phasebiocorporateoverc5e006.jpg GRAPHIC 98254
10 phasebiocorporateoverc5e007.jpg GRAPHIC 53466
11 phasebiocorporateoverc5e008.jpg GRAPHIC 104881
12 phasebiocorporateoverc5e009.jpg GRAPHIC 60536
13 phasebiocorporateoverc5e010.jpg GRAPHIC 140844
14 phasebiocorporateoverc5e011.jpg GRAPHIC 89921
15 phasebiocorporateoverc5e012.jpg GRAPHIC 103595
16 phasebiocorporateoverc5e013.jpg GRAPHIC 113893
17 phasebiocorporateoverc5e014.jpg GRAPHIC 100718
18 phasebiocorporateoverc5e015.jpg GRAPHIC 128709
19 phasebiocorporateoverc5e016.jpg GRAPHIC 119580
20 phasebiocorporateoverc5e017.jpg GRAPHIC 109333
21 phasebiocorporateoverc5e018.jpg GRAPHIC 93563
22 phasebiocorporateoverc5e019.jpg GRAPHIC 103785
23 phasebiocorporateoverc5e020.jpg GRAPHIC 67850
24 phasebiocorporateoverc5e021.jpg GRAPHIC 115902
25 phasebiocorporateoverc5e022.jpg GRAPHIC 79979
26 phasebiocorporateoverc5e023.jpg GRAPHIC 93625
27 phasebiocorporateoverc5e024.jpg GRAPHIC 119780
28 phasebiocorporateoverc5e025.jpg GRAPHIC 63318
29 phasebiocorporateoverc5e026.jpg GRAPHIC 124764
30 phasebiocorporateoverc5e027.jpg GRAPHIC 111994
31 phasebiocorporateoverc5e028.jpg GRAPHIC 54422
32 phasebiologo2a06.jpg GRAPHIC 136353
  Complete submission text file 0001169245-20-000042.txt   4212996
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 20754079
SIC: 2834 Pharmaceutical Preparations